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Abstract
Objective—Obesity is a risk factor for congenital heart defects (CHD), but whether risk is 
independent of abnormal glucose metabolism is unknown. Data on whether overweight status 
increases risk is also conflicting.
Research Design and Methods—We included 121815 deliveries from a cohort study, the 
Consortium on Safe Labor, after excluding women with pregestational diabetes as recorded in the 
electronic medical record. CHD were identified via medical record discharge summaries. Adjusted 
odds ratios (OR) for any CHD were calculated for prepregnancy body mass index (BMI) 
categories of overweight (25 to <30 kg/m2), obese (30 to <40 kg/m2), and morbidly obese (≥40 
kg/m2) compared to normal weight (18.5 to <25 kg/m2) women, and for specific CHD with obese 
groups combined (≥30 kg/m2). A sub-analysis adjusting for oral glucose tolerance test (OGTT) 
results where available was performed as a proxy for potential abnormal glucose metabolism 
present at the time of organogenesis.
Results—There were 1388 (1%) infants with CHD. Overweight (OR=1.15 95% CI: 1.01–1.32), 
obese (OR=1.26 95% CI: 1.09, 1.44), and morbidly obese (OR=1.34 95% CI: 1.02–1.76) women 
had greater odds of having a neonate with CHD than normal weight women (P< 0.001 for trend). 
Obese women (BMI ≥30 kg/m2) had higher odds of having an infant with conotruncal defects 
(OR=1.34 95%CI: 1.04–1.72), atrial septal defects (OR =1.22 95% CI: 1.04–1.43), and ventricular 
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septal defects (OR=1.38 95% CI: 1.06–1.79). Being obese remained a significant predictor of 
CHD risk after adjusting for OGTT.
Conclusion—Increasing maternal weight class was associated with increased risk for CHD. In 
obese women, abnormal glucose metabolism did not completely explain the increased risk for 
CHD; the possibility that other obesity-related factors are teratogenic requires further 
investigation.
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Prepregnancy BMI; Obesity; Congenital Heart Defects
Background and Significance
The majority of studies have found an association between maternal obesity and congenital 
heart defects (CHD).1–9 It is not clear whether the association between obesity and CHD can 
be explained by maternal diabetes, a known teratogen, because previous studies have not 
had detailed information on maternal glucose status. It is also not known whether mild 
elevations in maternal glucose could be responsible for the excess in CHD seen in offspring 
of obese women. This hypothesis is reasonable given that other adverse birth outcomes such 
as macrosomia have a linear association with maternal blood glucose even below the level 
that meets the criteria for a diagnosis of gestational diabetes.10, 11 Thus, data are needed to 
clarify whether obesity is in fact a risk factor for CHD independent of blood glucose level.
The literature is also conflicting regarding whether overweight status increases CHD 
risk.2, 3, 5, 6 Moreover, most studies have had insufficient numbers of subjects to investigate 
the relationship between obesity or overweight and classes of cardiac defects or individual 
defects.7
Using data from the Consortium on Safe Labor (CSL), a large United States cohort study, 
we investigated the association between prepregnancy body mass index (BMI) and odds of 
congenital cardiac defects overall and for specific defects where enough cases were 
available. In a subset of women with diabetes-screening data available, we also investigated 
the odds of CHD by weight status after adjusting for blood glucose levels.
Methods
Study Design and Methods
The Consortium on Safe Labor (CSL) was an observational study of medical records with 
prospectively entered data conducted by the Eunice Kennedy Shriver National Institute of 
Child Health and Human Development at 12 clinical centers (19 hospitals). It was designed 
to study contemporary obstetric management as well as maternal, obstetric, and neonatal 
outcomes given the changing maternal socio-demographics in regard to increased maternal 
age and body mass index (BMI).12, 13 Information on maternal demographic characteristics 
(including height, prepregnancy weight, race, educational attainment, insurance status, and 
age); medical, reproductive, and prenatal history (including pregestational diabetes status, 
parity, and smoking and alcohol use during pregnancy); pregnancy complications including 
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development of gestational diabetes mellitus (GDM); and labor, delivery, postpartum, and 
newborn outcomes was abstracted from electronic medical records. Information from the 
neonatal intensive care units (NICU) was linked to the newborn records. Maternal and 
newborn discharge summaries, in International Classification of Diseases-9 (ICD-9) codes, 
were linked to each delivery. CHD status for each infant was obtained via discharge record 
ICD-9 codes (Appendix A). Infants with isolated and multiple defects were examined 
together. Congenital heart defects were categorized as previously described14, and infants 
with more than one cardiac defect were categorized in a hierarchical fashion. Infants who 
had more than one cardiac defect were analyzed in each group. CHD cases related to 
aneuploidy were excluded.
The CSL study included 208695 women with 228562 deliveries at 23 weeks of gestation or 
later, occurring between 2002 and 2008. Women were excluded if they had multiple 
gestations (n=3234), were missing pre-pregnancy BMI information (n=76952), or had 
pregestational diabetes (n=18786). One site was excluded because it did not report 
pregestational diabetes status (n=7877). Women with missing BMI data had a higher 
percentage of neonates with CHD, compared to those with known BMI (1.7% versus 1.1%, 
p<0.01 by Chi-squared test). The critical period for most heart defects is 14 to 60 days after 
conception.2 Because gestational diabetes is usually not diagnosed until later in pregnancy 
around 24 – 28 weeks of gestation,15 we included women with gestational diabetes in the 
main analysis. However, since some women diagnosed as having gestational diabetes may 
have had undiagnosed diabetes during organogenesis, we performed a sensitivity analysis 
excluding all women with pregnancies complicated by gestational diabetes.
Statistical Analysis
Potential confounders were identified by comparing the distribution of baseline 
characteristics among women with infants with and without any type of CHD. For 
categorical factors, chi-squared tests were used. For continuous factors, t-tests were used. 
All factors with P≤0.05 were then included in a multivariable model. We adjusted for site to 
account for the potential differences in diagnoses by the different institutions. We adjusted 
for race and age because the Baltimore Washington Infant Heart Study reported race and age 
differences for some defects.16 The multivariable model related the odds ratio of having an 
infant with a CHD to categories of BMI (underweight: BMI < 18.5 kg/m2; normal weight: 
BMI 18.5 to < 25 kg/m2; overweight: BMI 25 to < 30 kg/m2; obese: BMI 30 to < 40 kg/m2; 
morbidly obese: BMI ≥ 40 kg/m2), while adjusting for each of the selected confounders, site, 
age, race, insurance, and maternal smoking. Women with multiple deliveries were accounted 
for in the model through a common random effect using PROC GENMOD of SAS.17 All 
reported tests were two-sided with P≤0.05 taken as statistically significant. SAS (SAS 
Institute Inc, Cary, NC) version 9.1 was used for the statistical analysis.
Additional models combined all obese subjects into a single group: BMI ≥ 30. Further 
models examined specific types of CHD where n >50, decided a priori. For each model a 
test for trend was obtained by replacing the categorical BMI with a continuous BMI term.
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Oral glucose tolerance test (OGTT) results were available at one site (n=5131). We 
performed a sub-analysis additionally adjusting for continuous OGTT results as a proxy for 
potential abnormal glucose metabolism present at the time of organogenesis.
Results
After the exclusions noted above, the study sample consisted of 121815 singleton births 
from 114819 women. There were 1388 cases of any type of CHD, 1.1% of the study 
population. Table 1 presents maternal characteristics. Mean maternal BMI was higher for 
women who had a neonate with any type of CHD compared to women whose neonates did 
not have CHD (26.3 kg/m2 versus 25.5 kg/m2, respectively, P<0.001). Compared to women 
who did not give birth to an infant with CHD, women who gave birth to infants with CHD 
were more likely to be overweight (25.4% compared to 23.7%) or obese (BMI ≥ 30 kg/m2) 
(22.6% versus 19.6%). Women whose infants had CHD were also less likely to be privately 
insured, and more likely to smoke during pregnancy and be diagnosed with gestational 
diabetes mellitus (GDM).
Increasing prepregancy BMI was associated with an increased odds for having an infant 
with CHD: 1.18-fold for overweight, 1.25-fold for obese, and 1.36-fold for morbidly obese 
women (P<0.001 for trend) (Table 2). These results remained significant but were slightly 
attenuated after adjusting for site, age, race, insurance, and maternal smoking. There was no 
association of CHD with underweight.
GDM complicated 2.2% of pregnancies of normal weight, 4.5% of overweight, and 8% of 
all obese women (≥ 30 kg/m2). Women who were diagnosed with GDM had significantly 
higher odds (OR=2.12 95% CI: 1.73, 2.59) of having a baby with any type of CHD. Because 
some women who developed GDM also might have had undiagnosed pregestational 
diabetes, we performed sensitivity analyses excluding all women who developed GDM. 
When women who developed GDM were excluded from the analytic population, the 
association between maternal BMI and infant CHD was attenuated but remained significant 
for the combined obesity categories (BMI ≥ 30 kg/m2) in the fully adjusted model: OR=1.18 
(95%CI: 1.02–1.36) (data not shown). The association was in the same direction but was no 
longer significant for overweight women: OR= 1.09 (95% CI: 0.95 – 1.25).
Regarding specific categories and types of CHD, the combined obesity group (BMI ≥ 30 
kg/m2) had significantly increased odds for conotruncal defects (OR=1.33 95% CI: 1.03–
1.72), ventricular septal defects (OR=1.38 95% CI: 1.06–1.79), and atrial septal defects 
(OR=1.22 95% CI: 1.04–1.43) (Table 3). There was no association between underweight or 
overweight status for any specific type of CHD in either crude or adjusted models.
To determine whether the association between pre-pregnancy BMI and CHD persisted after 
adjusting for glucose concentration later in pregnancy, we performed a sub-analysis 
restricted to the site that reported the results of 1-hour oral glucose tolerance test (OGTT) for 
more than 85% of women. This site had fewer women with missing BMI than the overall 
study population, and CHD incidence at this site was 0.92% (47 defects), which was similar 
to the 1.15% rate of CHD at sites that did not report OGTT values. We found after we 
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adjusted for OGTT as a linear predictor, there was a 6% increased odds of CHD with one 
unit increase in maternal BMI (adjusted OR=1.06, 95% CI 1.02 – 1.10) (Table 4). Among 
all women at the site with OGTT results (n=5131), obese women (BMI ≥ 30 kg/m2) had an 
OR for giving birth to an infant with any type of CHD of 1.96 (95% CI: 1.01, 3.80) (P=.045) 
in the crude model and 2.38 (95% CI: 1.02, 3.76) (P=.023) after adjusting for age and OGTT 
level. Moreover, the test for trend between increasing BMI and OR for congenital heart 
defects remained significant (P=.015) after adjusting for OGTT levels.
Discussion
In this large U.S. cohort study, obese and overweight women were more likely than normal 
weight women to deliver an infant with any CHD and among obese women, conotruncal, 
ventricular septal or atrial septal defects in particular. Increasing maternal BMI had a “dose- 
response” effect on CHD risk. Obesity remained a significant risk factor for CHD after 
adjusting for glycemic status as measured by oral glucose tolerance test (OGTT).
Women with BMIs above the normal range are more likely to have pre-gestational diabetes 
mellitus (DM), and diabetes is an established teratogen.18 Therefore, DM has been put forth 
as a possible explanation for the observed increased CHD risk in obese mothers.19 However, 
several studies have found the association persisted even after diabetic women were 
excluded.2, 4, 6, 8 One possible explanation might be obese and overweight women are more 
likely to have higher glucose concentrations that don’t meet the threshold for a diagnosis of 
diabetes. 6, 7 No study to date has been able to test this hypothesis. We used OGTT tests as a 
method of identifying possible glucose abnormalities during organogenesis. Even after 
adjusting for glucose status, increasing BMI was associated with increasing risk of CHD, 
and obese women still had higher risk of CHD.
The fact that maternal obesity was associated with risk of CHD even after taking abnormal 
glucose metabolism (albeit evaluated later in pregnancy) into account suggests that 
abnormalities in glucose metabolism do not fully explain the increased risk for CHD found 
in obese women. Furthermore, obesity remained a significant risk factor for CHD after we 
excluded all subjects with GDM (or undiagnosed pregestational diabetes), providing 
additional support for the hypothesis that other factors contribute to the increased risk for 
CHD in obese women. Obesity is associated with a wide range of metabolic abnormalities, 
but little is known about their potential teratogenicity. Our results raise important questions 
for future investigation. It has been hypothesized mothers with high pre-pregnancy BMI 
may be at higher risk of giving birth to an infant with CHD because obese women may be 
more likely to be dieting when they conceive;19 may have reduced folate levels;20 or may 
have more-difficult-to-read ultrasound scans, resulting in fewer terminations of pregnancy 
for fetal anomaly and therefore increased prevalence at birth.1, 7
Most studies have found that obesity was a risk factor for CHD, with similar effect sizes to 
our study. 2, 4–7 The data are much less consistent, however, regarding the risk associated 
with being overweight. Two prior case-control studies 2, 3 and two studies using birth 
certificate data with inherent limitations5, 6 did not find overweight to be associated with 
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CHD while other studies did, 1, 4, 8, 9 including a meta-analysis.7 Our study found 
overweight status had a modest effect on CHD risk after accounting for other factors.
We also examined the relationship between specific types of CHD and prepregnancy BMI 
and found that obese women were at an increased risk of having a neonate with conotruncal, 
ventricular septal, and atrial septal defects. Our findings are consistent with prior studies that 
found an association between obesity or morbid obesity and atrial and ventricular septal 
defects.2, 4, 6, 7, 19 Although our numbers of specific defects were small, our finding that 
overweight women were not at risk for giving birth to an infant with atrial or ventricular 
septal defects is similar to prior reports.4, 6, 7 Results have been more mixed for conotruncal 
defects. One study found an increased risk in obese mothers for conotruncal defects in 
general.4 In contrast, several studies have found no association between prepregnancy BMI 
for obese or overweight mothers and conotruncal defects in general5, 21, 22 or tetralogy of 
Fallot specifically.2, 7, 21, 22
Some limitations of our study should be noted. BMI data were not available on all women. 
However, CHD prevalence was somewhat higher in women with missing BMI data (1.68%) 
than those in the analytic population (1.15%). We did not have data on potential teratogens 
such as drugs, although they account for a small percentage of CHD. Cases not identified in 
the nursery or cases terminated prenatally were not available for study. Many cases of CHD, 
particularly atrial septal defects, ventricular septal defects, and Coarctation of aorta, may not 
be diagnosed before discharge after birth, and we did not have full clinical data on infants 
outside of ICD-9 discharge codes. Finally we were unable to account for any 
misclassification of ICD-9 coding, despite the fact classification for congenital heart disease 
has been shown to be inaccurate for certain types of defects, particularly tetralogy of Fallot, 
where the sensitivity was 83% based on ICD-9 reports.23
A major strength of our study was the ability to examine the role of potentially impaired 
glucose tolerance. Our study also had a large sample size, comprehensive maternal and 
infant demographic and delivery characteristics, and reliable, uniform data collection from 
medical charts. Because data were gathered prospectively from the medical records, several 
types of measurement error and bias, particularly recall bias, were greatly minimized.
Our findings have important public health implications considering that approximately two-
thirds of American women 20–39 are overweight or obese according to the 2009–2010 
National Health and Nutrition Examination Survey (NHANES) and are at greater risk of 
giving birth to a child with CHD.24 A simulation conducted by Honein et al. demonstrated 
that pre-pregnancy obesity may contribute to 2850 (95% CI: 1035–5065) CHD cases each 
year in the U.S. Worldwide, the burden of overweight and obesity is increasing, particularly 
in Latin America and the Caribbean, where 23% of women 20–29 are overweight and 11% 
are obese.25
Conclusion
In summary, women who were obese when they conceived were at increased risk of having 
an infant with a congenital heart defect. Abnormalities in glucose metabolism likely did not 
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completely explain the increased risk in obese women. Other obesity-related factors should 
be investigated as potential teratogens. Women should be counseled prior to conception that 
obesity increases the risk for CHD and that weight reduction may decrease their risk.
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